Tumor necrosis factor α Inhibition for Alzheimer’s Disease

Tumor necrosis factor α (TNF-α) plays a central role in the pathophysiology of Alzheimer’s disease (AD). Food and Drug Administration–approved biologic TNF-α inhibitors are thus a potential treatment for AD, but they do not cross the blood-brain barrier. In this short review, we discuss the involvem...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Rudy, Yee, Kei-Lwun, Sumbria, Rachita K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436834/
https://www.ncbi.nlm.nih.gov/pubmed/28579870
http://dx.doi.org/10.1177/1179573517709278

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436834/
https://www.ncbi.nlm.nih.gov/pubmed/28579870
http://dx.doi.org/10.1177/1179573517709278

Ejemplares similares